Analysis GMO Financial Holdings, Inc. (7177)
5/29/2024
Analysis of GMO Financial Holdings, Inc. (7177)
GMO Financial Holdings, Inc. (symbol: 7177) has been showing some interesting price movements and technical indicators in recent days. Here is a brief analysis based on the provided data:1. Price Movement:
- The closing price has been fluctuating between 695.00000 and 795.00000 in the past few days, showing some volatility in the stock.
- The stock opened at 681.00000 and reached a high of 810.00000, indicating significant price movements within a short period.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been fluctuating between 25.47750 and 66.75365, indicating some oscillation in the stock's momentum.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values have shown both positive and negative trends, suggesting potential shifts in the stock's direction.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a possible convergence in price trends.
3. Overall Analysis:
- The stock has shown volatility in price movements, with significant highs and lows in a short period.
- Technical indicators suggest mixed signals, with potential shifts in momentum and direction.
- Traders and investors may need to closely monitor the stock for further price movements and confirmatory signals from technical indicators before making any trading decisions.
Please note that this analysis is based on the provided data and should be supplemented with additional research and analysis for a comprehensive understanding of GMO Financial Holdings, Inc.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The fiscal year ends on September 30, 2023.In terms of income statement, the company has an EBITDA of $131.39 billion, revenue of $381.62 billion, and a net income to common of $100.39 billion. The most recent quarter ended on March 31, 2024, with a diluted EPS of 6.44 and a revenue per share of $24.54. The quarterly revenue and earnings growth are negative at -4.3% and -2.2% respectively.
The stock statistics show a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The stock has an average 10-day volume of 52.90 million and an average 90-day volume of 62.82 million. The stock price summary includes a beta of 1.26, with a 50-day moving average of $173.69 and a 200-day moving average of $180.79. The 52-week range is between $164.08 and $199.62.
In terms of valuation metrics, the company has a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price to book ratio of 39.18 and price to sales ratio of 7.62. The enterprise to EBITDA ratio is 22.75 and enterprise to revenue ratio is 7.73. The market capitalization stands at $2.91 trillion.
Lastly, the company's dividends and splits information include a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73% and the forward annual dividend yield is 0.53%.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an increase from the EPS of $6.59 reported for the current fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a significant sales growth of 6% compared to the current fiscal year.
Overall, the analysts are predicting moderate to strong sales growth for both the upcoming quarters and the next fiscal year, indicating positive performance and potential expansion for the company.
Growth estimates
Based on the consensus estimates provided:- The company is expected to have a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to have a compound annual growth rate (CAGR) of 11%.
- In the past 5 years, the company had a CAGR of approximately 20.1%.
Overall, the company is expected to experience steady growth in the upcoming periods, with a slightly higher growth rate in the long term compared to the short term.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price of the security is $191.57, which falls below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, such as net income and operating income, the trend in sales revenue shows consistent growth.
3. The company's ability to generate higher sales indicates a strong market position and effective sales strategies.
4. Investors and analysts can use the revenue trend to assess the company's overall performance and growth potential.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key metrics over the years.
MACD of 7177
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
